Ian Amanna

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.8MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20162022
AwardsPatents
Federal awards as principal investigator

4 awards · $3.8M

DateAgencyAwardAmountCompany
Aug 1, 2022NIHSTTR Phase I
Development of an improved intranasal vaccine against influenza
$275KNAJIT TECHNOLOGIES, INC.
with OREGON HEALTH & SCIENCE UNIVERSITY
Aug 1, 2019NIHSBIR Phase I
Optimization of vaccine antigen for the development of improved influenza
$224KNAJIT TECHNOLOGIES, INC.
Mar 1, 2017NIHSBIR Phase II
Development of an H2O2-inactivated chikungunya virus vaccine
$3.0MNAJIT TECHNOLOGIES, INC.
Aug 1, 2016NIHSTTR Phase I
Development of a novel platform to enhance intracellular bioavailability of antisense morpholino oligomers
$319KNAJIT TECHNOLOGIES, INC.
Among 4,078 researchers in Biotech

Peer ranks

Federal funding#427
Awards as PI#566
Patents#273
From filings, awards and patents

Companies

Research partners on awards

Research institutions

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.